ADAMTS9 and neoplasm: As previously reported, ADAMTS9-AS2 was shown to have an inhibitory role in NSCLC cell proliferation and migration, unearthing the potential tumor-suppressor role of this lncRNA in the development and progression of NSCLC [16].